| abstract |
The present disclosure relates to nanoparticles comprising surface molecules that bind or block PD-L1. In certain embodiments, the present disclosure relates to methods for treating cancer using the peptides or nanoparticles disclosed herein. In certain embodiments, the present disclosure relates to methods of using the nanoparticles disclosed herein for therapeutic and diagnostic applications. |